Literature DB >> 3758057

Pharmacokinetics of ciprofloxacin in peripheral lymph and skin blisters.

T Bergan, A Engeset, W Olszewski, N Ostby, R Solberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3758057     DOI： 10.1007/bf02075709

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN： 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  9 in total

1.  Studies on human peripheral lymph. I. Sampling method.

Authors:  A Engeset; B Hager; A Nesheim; A Kolbenstvedt
Journal:  Lymphology       Date:  1973-03       Impact factor: 1.286

2.  Pharmacokinetics and tissue penetration of ciprofloxacin.

Authors:  B Crump; R Wise; J Dent
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

3.  Pharmacokinetics of intravenously administered ciprofloxacin.

Authors:  R Wise; R M Lockley; M Webberly; J Dent
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

4.  Multiple-dose ciprofloxacin kinetics in normal subjects.

Authors:  G E Aronoff; C H Kenner; R S Sloan; S T Pottratz
Journal:  Clin Pharmacol Ther       Date:  1984-09       Impact factor: 6.875

5.  Human leucocyte migration: studies with an improved skin chamber technique.

Authors:  K B Hellum; C O Solberg
Journal:  Acta Pathol Microbiol Scand C       Date:  1977-12

6.  Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers.

Authors:  W Wingender; K H Graefe; W Gau; D Förster; D Beermann; P Schacht
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

7.  Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin.

Authors:  B Ledergerber; J D Bettex; B Joos; M Flepp; R Lüthy
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

8.  Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers.

Authors:  M A Gonzalez; F Uribe; S D Moisen; A P Fuster; A Selen; P G Welling; B Painter
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

9.  Pharmacokinetics of ciprofloxacin after intravenous and increasing oral doses.

Authors:  T Bergan; S B Thorsteinsson; I M Kolstad; S Johnsen
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267
  9 in total
  5 in total

1.  Pharmacokinetic quantification of the exchange of drugs between blood and cerebrospinal fluid in man.

Authors:  R Nau; G Zysk; A Thiel; H W Prange
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 2.  Clinical pharmacokinetics of ciprofloxacin.

Authors:  K Vance-Bryan; D R Guay; J C Rotschafer
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

Review 3.  Worldwide clinical data on efficacy and safety of ciprofloxacin.

Authors:  P Schacht; G Arcieri; J Branolte; H Bruck; V Chyský; E Griffith; G Gruenwaldt; R Hullmann; C A Konopka; B O'Brien
Journal:  Infection       Date:  1988       Impact factor: 3.553

Review 4.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

5.  Efficacy of ciprofloxacin-gentamicin combination therapy in murine bubonic plague.

Authors:  Nadine Lemaître; Isabelle Ricard; Elizabeth Pradel; Benoît Foligné; René Courcol; Michel Simonet; Florent Sebbane
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.